GNG4 and lung adenocarcinoma: Recent studies suggest that GNG4 expression is elevated in a variety of tumours, including colorectal, colon, gastric, lung adenocarcinoma, and gallbladder cancers, and is associated with poor prognosis in patients with these cancer types (19–24).